Henry James International Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-43,070
| Closed | -$162K | – | 121 |
|
|
2021
Q4 | $162K | Hold |
43,070
| – | – | 0.05% | 142 |
|
|
2021
Q3 | $223K | Hold |
43,070
| – | – | 0.07% | 142 |
|
|
2021
Q2 | $183K | Sell |
43,070
-43,000
| -50% | -$183K | 0.05% | 155 |
|
|
2021
Q1 | $457K | Buy |
+86,070
| New | +$457K | 0.14% | 123 |
|
|
2019
Q1 | – | Sell |
-25,027
| Closed | -$144K | – | 144 |
|
|
2018
Q4 | $144K | Buy |
+25,027
| New | +$144K | 0.09% | 136 |
|